Zenas BioPharma Inc.

NASDAQ: ZBIO · Real-Time Price · USD
16.82
0.06 (0.36%)
At close: Aug 15, 2025, 3:59 PM
17.00
1.07%
After-hours: Aug 15, 2025, 05:40 PM EDT

Zenas BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
319.74M 56.86M 67.21M
Short-Term Investments
31.02M n/a n/a
Long-Term Investments
n/a 86K 86K
Other Long-Term Assets
12.86M 7.28M 4.25M
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
5.16M 2.95M 1.24M
Total Current Assets
355.92M 59.8M 68.44M
Property-Plant & Equipment
1.19M 1.01M 1.8M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
14.04M 8.38M 6.13M
Total Assets
369.97M 68.18M 74.58M
Account Payables
17.14M 5.4M 5.82M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
785K 556K 715K
Other Current Liabilities
-785K 4.57M 3.62M
Total Current Liabilities
57.29M 23.26M 25.97M
Long-Term Debt
n/a 20.3M n/a
Other Long-Term Liabilities
n/a 250.09M 240.09M
Total Long-Term Liabilities
218K 270.64M 240.9M
Total Liabilities
57.51M 293.9M 266.87M
Total Debt
1M 21.11M 1.53M
Common Stock
4K 1K 1K
Retained Earnings
-387.39M -230.4M -193.28M
Comprehensive Income
194K 37K -41K
Shareholders Equity
312.46M -225.72M -192.29M
Total Investments
31.02M 86K 86K